Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small-Molecule API Manufacturing Capacity in Delaware

Wilmington PharmaTech ("Wilmington"), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 ...
Fierce Pharma

CDMO Axplora to pump $60M into Italian complex API plant

Axplora, a German CDMO that specializes in specialty active pharmaceutical ingredients for small molecules and antibody-drug ...
Business Facilities

$195M AbbVie Expansion Boosts Illinois Pharma Industry

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...
Business Wire

The API Innovation Center, Apertus Pharmaceuticals Bring API Production of Critical Generic Cancer Drug to U.S. Soil

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
MyCentralJersey

Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
NJBIZ

Cambrex to invest $120M to expand U.S. drug production

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
Pakistan TodayOpinion

API manufacturing in Pakistan

Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production ...